Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
---|---|---|---|---|---|---|
Q3 2024 | 7 | 46,512 | LENZ, KRRO, ANRO, PRAX | 13F-HR | 11/14/2024 | 000090266424006613 |
Q2 2024 | 7 | 39,787 | LENZ, KRRO, ANRO, PRAX | 13F-HR | 8/14/2024 | 000090266424005144 |
Q1 2024 | 7 | 67,080 | KRRO, LENZ THERAPEUTICS INC, ALTO NEUROSCIENCE INC, PRAX | 13F-HR | 5/15/2024 | 000090266424003613 |
Q4 2023 | 6 | 22,520 | KRRO, CRBU, TRDA, PRAX | 13F-HR | 2/14/2024 | 000090266424001731 |
Q3 2023 | 5 | 14,925 | TRDA, CRBU, TSBX, PRAX | 13F-HR | 11/14/2023 | 000090266423005504 |
Q2 2023 | 4 | 12,835 | TRDA, CRBU, OMGA, PRAX | 13F-HR | 8/14/2023 | 000090266423004436 |
Q1 2023 | 5 | 211,156 | RXDX, TRDA, CRBU, OMGA | 13F-HR | 5/15/2023 | 000090266423003105 |
Q4 2022 | 5 | 217,510 | RXDX, TRDA, CRBU, PRAX | 13F-HR | 2/14/2023 | 000089914023000427 |
Q3 2022 | 5 | 126,233 | RXDX, TRDA, CRBU, PRAX | 13F-HR | 11/14/2022 | 000156761922020127 |
Q2 2022 | 5 | 64,708 | RXDX, TRDA, CRBU, PRAX | 13F-HR | 8/15/2022 | 000156761922016264 |
Q1 2022 | 6 | 91,417 | RXDX, PRAX, TRDA, CRBU | 13F-HR | 5/16/2022 | 000156761922010957 |
Q4 2021 | 6 | 112,679 | RXDX, PRAX, TRDA, CRBU | 13F-HR | 2/14/2022 | 000156761922004414 |
Q3 2021 | 4 | 80,073 | RXDX, PRAX, CRBU, OMGA | 13F-HR | 11/15/2021 | 000156761921020486 |
Q2 2021 | 2 | 63,466 | RXDX, PRAX | 13F-HR | 8/16/2021 | 000156761921015929 |
Q1 2021 | 2 | 66,144 | RXDX, PRAX | 13F-HR | 5/17/2021 | 000156761921010570 |
Q4 2020 | 2 | 742,163 | PLTR, PRAX | 13F-HR | 2/16/2021 | 000156761921004069 |